Clinical Trial

Effects of QUANTUM Probe for Skin Rejuvenation and Subdermal Retraction in Patients Undergoing High-Definition Liposculpture

Study acronym: Quantum001
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated May 6, 2025 (before its estimated December 2025 completion). Its status may not reflect the trial's current state.
Summary
This prospective study aims to evaluate the safety and effectiveness of Quantum, a fully internal bipolar radiofrequency probe, for the treatment of prominent skin laxity, providing patients with a more toned and youthful appearance, in patients undergoing High-Definition (HD) Liposculpture. The main questions this study seeks to answer are: * Does Quantum reduce skin laxity in patients undergoing HD Liposculpture? * Is the effectiveness in skin laxity reduction influenced by demographical factors, including age, gender, and phototype? The participants will be adult patients (between 18-60 years) undergoing HD Liposculpture, with any measurable degree of skin laxity. The participants can not be pregnant, have history of scaring/healing problems, autoimmune diseases, severe dermatological conditions, have metal implants, be obese, or have important comorbidities.
Trial Details
NCT Number NCT06958978
Lead Sponsor Total Definer Research Group
Conditions Skin Laxity, Skin Tightening, Body Contouring Surgery, Skin Elasticity, Skin Firmness, Liposuction
Enrollment 80 participants
Start Date 2024-02-01
Primary Completion 2025-12 (estimated)
Study Completion 2026-06 (estimated)
Updated on ClinicalTrials.gov 2025-05-06